Effects of Intermittent Theta Burst Stimulation in Addition to Constraint-Induced Movement Therapy in Stroke Patients

Sponsor
Istanbul Medeniyet University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05308667
Collaborator
Istanbul University - Cerrahpaşa (Other)
33
1
3
23.4
1.4

Study Details

Study Description

Brief Summary

In recent studies, it has been reported that intermittent theta-burst stimulation (iTBS) provides additional benefits when applied in adjunct to the rehabilitation in all stages of stroke (acute, subacute, or chronic). In our study, it was aimed to evaluate the effectiveness of iTBS applied in addition to modified constraint-induced movement therapy (mCIMT). By doing so, we intend to increase patient adherence to neurorehabilitation and decrease the cost of rehabilitation.

Condition or Disease Intervention/Treatment Phase
  • Other: Rehabilitation (modified constraint-induced movement therapy)
  • Other: non-invasive brain stimulation (intermittent theta-burst stimulation)
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
33 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
Effects of Intermittent Theta Burst Stimulation in Addition to Constraint-Induced Movement Therapy in Stroke Patients
Actual Study Start Date :
Jun 2, 2022
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
May 15, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: iTBS + mCIMT group

Other: Rehabilitation (modified constraint-induced movement therapy)
Modified constraint-induced movement therapy (mCIMT): It is an intervention used to improve functionality and mobility in the more affected upper extremity post-stroke.

Other: non-invasive brain stimulation (intermittent theta-burst stimulation)
Intermittent theta-burst stimulation (iTBS): It is a form of repetitive transcranial magnetic stimulation and it increases the facilitation of the motor cortex.

Sham Comparator: Sham iTBS+ mCIMT group

Other: Rehabilitation (modified constraint-induced movement therapy)
Modified constraint-induced movement therapy (mCIMT): It is an intervention used to improve functionality and mobility in the more affected upper extremity post-stroke.

Other: non-invasive brain stimulation (intermittent theta-burst stimulation)
Intermittent theta-burst stimulation (iTBS): It is a form of repetitive transcranial magnetic stimulation and it increases the facilitation of the motor cortex.

Active Comparator: mCIMT group

Other: Rehabilitation (modified constraint-induced movement therapy)
Modified constraint-induced movement therapy (mCIMT): It is an intervention used to improve functionality and mobility in the more affected upper extremity post-stroke.

Outcome Measures

Primary Outcome Measures

  1. Fugl-Meyer Assessment-Upper extremity [30 minutes]

    The Fugl-Meyer Assessment (FMA) is a stroke-specific, performance-based impairment index. It is designed to assess motor functioning, balance, sensation and pain.

  2. Wolf-Motor Function Test [45 minutes]

    It is a new time-based method to evaluate upper extremity performance while providing insight into joint-specific and total limb movements

Secondary Outcome Measures

  1. Motor Evoked Potentials (MEPs) [10 minutes]

    MEPs are the electrical signals recorded from the descending motor pathways or from muscles following stimulation of motor pathways within the brain.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • First time and unilateral stroke

  • 1-12 months after the incident

  • Getting 24 points or more in Mini Mental Status Examination

  • Being able to stand for 2 minutes without any help by using the upper extremity as a support tool when necessary.

  • Being a low-functioning patient according to the CIMT criteria: a) At least 10 degrees of active wrist extension starting from the angle of full flexion, b) 10 degrees of extension at the metacarpophalangeal and inter-phalangeal joints of at least 2 fingers

Exclusion Criteria:
  • those who score more than 2.5 points on the Motor Activity Log-28 scale,

  • who have severe pain in the upper extremity (5 and above on the Visual Analogue Scale) and spasticity (3 and above on the Modified Ashworth Scale), which may affect the treatment, and

  • Those who do not have adequate communication skills.

  • Patients who have visual problems

Contacts and Locations

Locations

Site City State Country Postal Code
1 Bakırköy Mazhar Osman Ruh ve Sinir Hastalıkları Hastanesi İstanbul Turkey 34394

Sponsors and Collaborators

  • Istanbul Medeniyet University
  • Istanbul University - Cerrahpaşa

Investigators

  • Study Director: Burcu Ersöz Hüseyinsinoğlu, Assoc. Prof., Marmara University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Esma Nur KOLBAŞI, Researcher, Istanbul Medeniyet University
ClinicalTrials.gov Identifier:
NCT05308667
Other Study ID Numbers:
  • IstanbulMU64
First Posted:
Apr 4, 2022
Last Update Posted:
Jun 24, 2022
Last Verified:
Jun 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 24, 2022